Poor breast cancer prognosis associated with presence of circulating tumor, cancer stem cells
Friday, December 10, 2010 - 14:30
in Health & Medicine
Metastatic breast cancer patients whose blood contains circulating tumor cells (CTCs) before or after treatment with high-dose chemotherapy and blood stem cell transplant have shorter survival periods, according to a new study by researchers at The University of Texas MD Anderson Cancer Center in Houston.